Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. futures hold steady ahead of Fed minutes; Dow Jones down 0.06%

Published 07/09/2014, 06:47 AM
Updated 07/09/2014, 06:47 AM
U.S. futures little changed, eyes on Fed minutes

Investing.com - U.S. stock futures pointed to a steady open on Wednesday, as markets were eyeing the Federal Reserve's meeting minutes, due to be released later in the day.

Ahead of the open, the Dow 30 futures pointed to a 0.06% loss, S&P 500 futures signaled a 0.02% downtick, while the Nasdaq 100 futures indicated a 0.02% dip.

U.S. stocks found support amid speculation recent U.S. data showing that the labor market is continuing to strengthen will not be enough to prompt the Fed to bring forward its timetable for raising interest rates.

Last week, data showed that the U.S. economy added a larger-than-forecast 288,000 jobs last month, while the unemployment rate ticked down to 6.1%, the lowest in almost six years.

But investors remained cautious amid growing expectations that the Fed will stick to its dovish stance on monetary policy amid concerns over ongoing slow growth in inflation and wages.

Alcoa (NYSE:AA) shares rallied 1.68% in pre-market trade after the aluminum producer reported late Tuesday earnings that exceeded expectations and said its restructuring charges had diminished and its core metals unit delivered strong growth.

In the financial sector, Citigroup (NYSE:C) gained 0.74% in extended trade amid reports the bank is close to paying about $7 billion to resolve a U.S. probe into whether it defrauded investors on billions of dollars worth of mortgage securities before the financial crisis.

Amazon.com (NASDAQ:AMZN) was also set to be in focus after it said it is offering authors caught up in its dispute with Hachette Book Group all of the proceeds from the sale of any digital book.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Elsewhere, AbbVie (NYSE:ABBV) slipped 0.18% after-hours as the maker of the arthritis drug Humira made a fourth offer on Tuesday to buy U.K. drugmaker Shire (LONDON:SHP) for $51.6 billion. The offer values the Dublin-based company 48% higher than before AbbVie first approached it in May.

Across the Atlantic, European stock markets were mostly lower. The DJ Euro Stoxx 50 added 0.10%, France’s CAC 40 edged down 0.12%, Germany's DAX dipped 0.02%, while Britain's FTSE 100 declined 0.60%.

During the Asian trading session, Hong Kong's Hang Seng plummeted 1.55%, while Japan’s Nikkei 225 eased 0.08%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.